What are the normal serum and red‑cell folate concentrations, and how should folate deficiency be treated?

Normal Folate Concentrations and Treatment of Deficiency

Normal serum folate should be ≥25 nmol/L (approximately 11 ng/mL) and red blood cell (RBC) folate should be ≥748 nmol/L (approximately 340 ng/mL) for optimal neural tube defect prevention, with folate deficiency treated using 400 mcg (0.4 mg) daily for general supplementation or 4-5 mg daily for high-risk individuals.

Normal Reference Ranges

Serum Folate

The evidence demonstrates evolving understanding of optimal folate thresholds:

• Traditional lower limit: 3.0 ng/mL has been historically used, but this is insufficient for optimal health outcomes 1
• Optimal threshold for NTD prevention: 25-25.6 nmol/L (approximately 11-11.5 ng/mL) based on population studies 2, 3
• Functional deficiency marker: Serum folate <7.0 ng/mL is associated with malnutrition markers and should prompt evaluation 4
• Depletion threshold: Levels <8 μg/L (18 nmol/L) show positive effects on homocysteine elevation 5

Important caveat: The serum folate threshold is substantially modified by vitamin B12 status. In populations with vitamin B12 deficiency (<148 pmol/L), the required serum folate threshold increases to 72.5 nmol/L, more than 2-fold higher than in B12-sufficient individuals 3. This makes serum folate thresholds unreliable in B12-deficient populations.

Red Blood Cell Folate

• Optimal for NTD prevention: ≥748 nmol/L (≥340 ng/mL) or ≥906 nmol/L (≥400 ng/mL) depending on the study 2, 6
• Deficiency: <305 nmol/L 3
• RBC folate is the preferred marker as it reflects tissue stores and is less affected by recent dietary intake than serum folate 5

Treatment of Folate Deficiency

General Population

For all women of reproductive age (whether planning pregnancy or not):

• 400 mcg (0.4 mg) daily of folic acid through supplements, multivitamins, fortified foods, or combination 7, 8
• Should be taken throughout reproductive years, particularly before conception and through first trimester
• This dose achieves substantial NTD reduction (40-80%) 8

High-Risk Individuals

4-5 mg daily starting 3 months before conception and continuing through first trimester for women with 7:

• Previous NTD-affected pregnancy
• Personal history of NTD
• First- or second-degree relative with NTD
• Type 1 diabetes mellitus
• Seizure disorders treated with valproate or carbamazepine

The guidelines specify that 5 mg will not mask vitamin B12 deficiency in women of reproductive age 7, though this remains a theoretical concern in older populations.

Critical Clinical Pitfalls

1. Always exclude vitamin B12 deficiency before folate supplementation 4. Folate can mask the hematologic manifestations of B12 deficiency while allowing neurologic damage to progress, particularly in patients >65 years old 7, 8.

2. Serum folate <7.0 ng/mL indicates malnutrition risk: 62.4% of patients with levels this low have one or more malnutrition markers 4. Evaluate for:

   • Gastrointestinal disorders
   • Chronic kidney disease
   • Sepsis
   • Low albumin and prealbumin

3. RBC folate testing is more clinically meaningful than serum folate for assessing true tissue deficiency, as serum levels fluctuate with recent intake 5.

4. Vitamin B12 status profoundly affects folate thresholds: In populations with B12 insufficiency, standard serum folate cutoffs are unreliable and substantially higher thresholds are needed 3.

5. Current US population data (2011-2016) shows approximately 18-23% of women of reproductive age still have folate insufficiency despite fortification 6, indicating ongoing need for supplementation beyond dietary sources alone.